Glenmark Pharmaceuticals has informed about press release titled ‘Glenmark Pharmaceuticals Presents New Data on Ryaltris, an Investigational Product for the Treatment of Seasonal Allergic Rhinitis at the AAAAI/WAO Joint Congress’.
The above information is a part of company’s filings submitted to BSE.